PharmaResources (Shanghai) Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 16.35%

PharmaResources (Shanghai) Co. Ltd. A (301230) has an Asset Resilience Ratio of 16.35% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥215.15 Million

≈ $31.48 Million USD Cash + Short-term Investments

Total Assets

CN¥1.32 Billion

≈ $192.55 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how PharmaResources (Shanghai) Co. Ltd. A's Asset Resilience Ratio has changed over time. See PharmaResources (Shanghai) Co. Ltd. A free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down PharmaResources (Shanghai) Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is PharmaResources (Shanghai) Co. Ltd. A worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥215.15 Million	16.35%
Total Liquid Assets	CN¥215.15 Million	16.35%

Asset Resilience Insights

Good Liquidity Position: PharmaResources (Shanghai) Co. Ltd. A maintains a healthy 16.35% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

PharmaResources (Shanghai) Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare PharmaResources (Shanghai) Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for PharmaResources (Shanghai) Co. Ltd. A (2021–2025)

The table below shows the annual Asset Resilience Ratio data for PharmaResources (Shanghai) Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	18.95%	CN¥248.98 Million ≈ $36.43 Million	CN¥1.31 Billion ≈ $192.29 Million	-0.18pp
2024-12-31	19.13%	CN¥251.77 Million ≈ $36.84 Million	CN¥1.32 Billion ≈ $192.63 Million	-3.79pp
2023-12-31	22.92%	CN¥340.79 Million ≈ $49.87 Million	CN¥1.49 Billion ≈ $217.62 Million	+22.10pp
2022-12-31	0.82%	CN¥10.65 Million ≈ $1.56 Million	CN¥1.30 Billion ≈ $190.42 Million	+0.75pp
2021-12-31	0.07%	CN¥397.68K ≈ $58.19K	CN¥557.81 Million ≈ $81.62 Million	--

pp = percentage points

About PharmaResources (Shanghai) Co. Ltd. A

SHE:301230 China Biotechnology

Market Cap

$500.03 Million

CN¥3.42 Billion CNY

Market Cap Rank

#12069 Global

#3446 in China

Share Price

CN¥24.48

Change (1 day)

+0.16%

52-Week Range

CN¥22.55 - CN¥65.76

All Time High

CN¥65.76